BioSpace News Archive

Jasper Therapeutics, Inc. (NASDAQ: JSPR), a biotechnology company focused on enabling cures with stem cell therapies, today announced that the Company will participate at the LifeSci Partners 2nd Annual Genetic Medicines Symposium on June 28, 2022.

Novavax, Inc. (Nasdaq: NVAX), today announced that the Taiwan Food and Drug Administration has granted emergency use authorization (EUA) for Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine in individuals aged 18 years and over.

According to Vision Research Reports, the global healthcare staffing market size is expected to be worth around US$ 50 billion by 2030 from valued at US$ 33 billion in 2021 and is anticipated to grow at a CAGR of 5.5% during forecast period 2022 to 2030.

As per Vision Research Reports, the global life sciences BPO market size surpassed at US$ 370 billion in 2021 and is expected to surpass around US$ 850 billion by 2030 with a registered CAGR of 12% from 2022 to 2030.

BioSig Technologies, Inc., a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, announced that it intends to offer shares of its common stock in a “best efforts” underwritten public offering.

Blueprint Medicines Corporation (NASDAQ: BPMC) today announced the appointment of Habib Dable to its board of directors.

Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) today announced the results of its 2022 annual meeting of shareholders and certain other updates with respect to the Company’s Board of Directors (the “Board”).

Astrotech Corporation (Nasdaq: ASTC) announced today that it has appointed Jim Becker to its Board of Directors.

Quotient Limited, a commercial-stage diagnostics company, announced the Company intends to commence an underwritten public offering of $20 million of its ordinary shares and, to certain investors in lieu of ordinary shares, pre-funded warrants.

Quotient Limited announced that in connection with the public offering announced, the Company has agreed with the beneficial owners of all $132.9 aggregate principal amount of its 12% Senior Secured Notes due 2025 to amend the indenture governing the SSNs to.